Kestra Medical price target raised to $25 from $22 at Goldman Sachs

Banco Macro downgraded to Hold from Buy at HSBC

Arcus Biosciences price target lowered to $44 from $56 at Citi

Oroco Resource downgraded to Speculative Buy from Buy at Cantor Fitzgerald

Transcontinental price target raised to C$29 from C$26 at RBC Capital

Suncor price target raised to C$73 from C$71 at TD Securities

Empire Company price target lowered to C$50 from C$58 at TD Securities

Dollarama price target raised to C$235 from C$210 at TD Securities

Lundin Mining price target raised to C$30 from C$24 at CIBC

Empire Company price target lowered to C$53 from C$59 at CIBC

Dollarama price target raised to C$212 from C$199 at CIBC

TerraVest price target raised to C$179 from C$165 at Scotiabank

Dollarama price target raised to C$220 from C$205 at Scotiabank

Lanxess price target lowered to EUR 19 from EUR 23 at Citi

ImmunityBio price target raised to $9 from $8 at Jefferies

Societe Generale price target raised to EUR 81 from EUR 70 at Citi

Repsol price target raised to EUR 20 from EUR 17 at Barclays

OMV AG price target raised to EUR 47 from EUR 43 at Barclays

Eni price target raised to EUR 20 from EUR 18.50 at Barclays

BP price target raised to 590 GBp from 525 GBp at Barclays

Arcus Biosciences price target raised to $32 from $28 at H.C. Wainwright

Genpact initiated with a Neutral at Susquehanna

TD Cowen Reiterates Buy Rating on BioCryst Pharma (BCRX)

Garrett Motion price target raised to $22 from $17 at BWS Financial

NewLake Capital Partners upgraded to Buy at Lucid on potential cannabis reform

Citi places Ideaya on 'upside 90-day catalyst watch' into data

UBS Reiterates Buy Rating on Kinder Morgan (KMI)

ResMed (RMD) PT Raised to $345 at UBS

UBS Reiterates Neutral Rating on Hubbell (HUBB) Ahead of Q4 Results

Weyerhaeuser price target raised to $28 from $27 at CIBC

DoorDash Inc. (DASH) PT Lowered to $260 at Argus

UBS on Costco Wholesale (COST): 'We See a Compelling Opportunity to Own the Stock'

Idaho Strategic price target raised to $45 from $35 at Roth Capital

Lululemon price target raised to $215 from $200 at Telsey Advisory

UBS Confident Linde (LIN) Can Deliver 10%+ Earnings Growth Over Time

Gold Royalty price target raised to $5 from $4 at Scotiabank

Restoration Hardware (RH) PT Lowered to $188 at UBS as 'Risk-Reward Fairly Balanced'

Netskope price target raised to $26 from $25 at Deutsche Bank

Broadcom price target raised to $430 from $400 at Deutsche Bank

Bio-Techne price target raised to $72 from $66 at Deutsche Bank

Galp Energia downgraded to Hold from Buy at Jefferies

Roivant Sciences price target raised to $26 from $23 at H.C. Wainwright

Netskope price target raised to $27 from $26 at RBC Capital

Southern Company price target lowered to $99 from $107 at RBC Capital

Linde price target lowered to $490 from $540 at RBC Capital

Stellantis NV (STLA) PT Raised to $13 at TD Cowen

General Motors (GM) PT Raised to $110 at TD Cowen

TD Cowen on Costco Wholesale (COST): 'Recent Pullback Creates Opportunity'

Southwest price target raised to $42 from $31 at TD Cowen

Synopsys price target raised to $550 from $510 at Morgan Stanley

Broadcom Limited (AVGO) PT Raised to $450 at TD Cowen Post 'Strong Results/Guide'

Exxon Mobil price target raised to $135 from $128 at TD Cowen

Benchmark Reiterates Buy Rating on XOMA, Ltd. (XOMA) Despite Rezolute Setback

RXO, Inc. (RXO) 'One of the Most Recovery-Dependent Names,' Says Analyst

Benchmark Reiterates Buy Rating on The Chefs' Warehouse, Inc (CHEF)

Broadcom price target raised to $485 from $385 at Benchmark

Broadcom price target raised to $450 from $405 at TD Cowen

Wave Life Sciences price target raised to $37 from $19 at B. Riley

RealReal price target raised to $17 from $14 at B. Riley

FormFactor price target raised to $78 from $66 at B. Riley

Frequency Electronics price target raised to $46 from $43 at Craig-Hallum

Ciena price target raised to $222 from $113 at B. Riley

ARC Resources downgraded to Neutral from Buy at UBS

Ciena price target raised to $230 from $120 at UBS

Comstock Resources price target raised to $18 from $16 at UBS

Freeport-McMoRan price target raised to $60 from $55 at UBS

Gulfport Energy price target raised to $264 from $227 at UBS

Matador price target raised to $50 from $46 at UBS

Peabody price target raised to $29 from $27 at UBS

Southern Copper price target raised to $143 from $135 at UBS

SLB price target raised to $50 from $44 at UBS

Range Resources price target raised to $43 from $38 at UBS

Permian Resources price target raised to $19 from $17 at UBS

TRX Gold price target raised to $1.25 from 85c at Roth Capital

Ovintiv price target raised to $55 from $54 at UBS

Murphy Oil price target raised to $31 from $27 at UBS

Empire Company (EMP/A:CN) (EMLAF) PT Lowered to Cdn$51 at BMO Capital

Diamondback Energy price target raised to $194 from $174 at UBS

Ciena price target raised to $195 from $185 at Morgan Stanley

Expand Energy price target raised to $154 from $132 at UBS

EQT Corporation price target raised to $76 from $67 at UBS

ConocoPhillips price target raised to $120 from $117 at UBS

Civitas Resources price target raised to $29 from $27 at UBS

Freddie Mac upgraded to Outperform from Underperform at Wedbush

Baker Hughes price target raised to $54 from $48 at UBS

Antero Resources price target raised to $46 from $40 at UBS

Bristol Myers price target raised to $37 from $36 at Morgan Stanley

APA Corp. price target raised to $30 from $26 at UBS

Alcoa price target raised to $48 from $42 at UBS

EOG Resources price target lowered to $141 from $144 at UBS

Structure Therapeutics price target raised to $125 from $120 at Morgan Stanley

Gilead price target raised to $151 from $147 at Morgan Stanley

AbbVie price target raised to $269 from $261 at Morgan Stanley

PPL Corp. price target raised to $45 from $43 at Wells Fargo

Piper Sandler on Netskope (NTSK): 'Impressive 3Q Results'

Flutter Entertainment price target lowered to $315 from $352 at Morgan Stanley

Kestra Medical price target raised to $28 from $27 at Wells Fargo

Playtech downgraded to Underweight from Equal Weight at Morgan Stanley

Antero Resources price target raised to $49 from $39 at Wells Fargo

Carnival price target raised to $35 from $34 at Wells Fargo